March 30, 2017
Sponsored by
SeraCare

Roundtable Discussion: Best Practices for Validation, Monitoring, and Controls

GenomeWebinar

Principal, M.D, JD Consulting

Medical Director, Molecular Genetics and Genomics, ARUP Laboratories

Director of Laboratory Science, Palmetto GBA

Our roundtable of industry experts provide an overview of the current regulatory landscape for clinical genomics tests. The panelists discuss how clinical labs can and should ensure the analytical and clinical validity of their tests amid an uncertain regulatory climate. 

*This webinar is part 1 of 4 - Catalyzing Implementation of NGS-based Tests: A Webinar Series 

Sponsored by

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.